Your Location：
Home >
Browse articles >
Preclinical pharmacology study of neutral myocardial imaging agent 99mTcN(NOEt)2
Updated：2021-02-05
|
Preclinical pharmacology study of neutral myocardial imaging agent 99mTcN(NOEt)2
- Nuclear Science and Techniques Vol.10, Issue 1, (1999)
Published：01 February 1999，
Received：07 September 1998
Scan the full text
Cite this article
0
Views
0
Downloads
0
Cited
Alert me when the article has been cited
Submit
Tools
Download
Export Citation
Share
Add to favorites
Add to my album
Related Articles
The preclinical pharmacological study of dopamine transporter imaging agent 18F-FP-β-CIT
Biological evaluation on 125I-ADAM as serotonin transporter ligand
Preliminary evaluation of the radiotherapeutic efficacy of 131I-atorvastatin in rats with hepatocellular carcinoma
Preparation and biodistribution assessment of 68Ga-DKFZ-PSMA-617 for PET prostate cancer imaging
Synthesis and biological evaluation of 18F-FB-NGA as a hepatic asialoglycoprotein receptor PET imaging agent
Related Author
Xiaomin LI
Zhengping CHEN
Songpei WANG
Jie TANG
Yansong LIN
Zhaohui ZHU
Ping FANG
Bei LEI
Related Institution
PET Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Jiangsu Institute of Nuclear Medicine, Key Laboratory of Nuclear Medicine, Ministry of Health
Huashan Hospital, Fudan University
The Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Institute of Nuclear Medicine
.O. BOX
0